Cargando…
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland
AIM: Even though most pregnancies are uneventful, occasionally complications do occur. Gestational diabetes is linked to an increased risk of adverse pregnancy outcomes. Early identification of women at risk of experiencing adverse outcomes, ideally through a single blood test, would facilitate earl...
Autores principales: | Bogdanet, Delia, Castillo, Michelle Toth, Doheny, Helen, Dervan, Louise, Luque-Fernandez, Miguel Angel, Halperin, Jose A., O’Shea, Paula M., Dunne, Fidelma P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617525/ https://www.ncbi.nlm.nih.gov/pubmed/36309618 http://dx.doi.org/10.1007/s00592-022-01983-z |
Ejemplares similares
-
The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland
por: Bogdanet, Delia, et al.
Publicado: (2022) -
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland
por: Bogdanet, Delia, et al.
Publicado: (2022) -
The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia—Subanalysis of the DALI Study
por: Bogdanet, Delia, et al.
Publicado: (2022) -
Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) – protocol for prospective cohort study
por: Bogdanet, D., et al.
Publicado: (2020) -
Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review
por: Bogdanet, Delia, et al.
Publicado: (2021)